Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year Follow-Up Study

Heart failure (HF) represents a widespread health problem characterized by high morbidity and mortality. Sacubitril/Valsartan (sac/val) has improved clinical prognosis in patients affected by HF with reduced ejection fraction (HFrEF). The aim of this study was to evaluate the effectiveness and durab...

Descripción completa

Detalles Bibliográficos
Autores principales: Armentaro, Giuseppe, D’Arrigo, Graziella, Magurno, Marcello, Toscani, Alfredo F., Condoleo, Valentino, Miceli, Sofia, Cassano, Velia, Maio, Raffaele, Arturi, Franco, Tripepi, Giovanni, Sesti, Giorgio, Sciacqua, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415264/
https://www.ncbi.nlm.nih.gov/pubmed/34483943
http://dx.doi.org/10.3389/fphar.2021.733475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415264/
https://www.ncbi.nlm.nih.gov/pubmed/34483943
http://dx.doi.org/10.3389/fphar.2021.733475

Ejemplares similares